Literature DB >> 6707678

The response of the apparent receptive speech disorder of Parkinson's disease to speech therapy.

S Scott, F I Caird.   

Abstract

Eleven patients with Parkinson's disease were tested for prosodic abnormality, on three tests of speech production (of angry, questioning, and neutral statement forms), and four tests of appreciation of the prosodic features of speech and facial expression. The tests were repeated after a control period of two weeks without speech therapy and were not substantially different. After two weeks of intensive domiciliary prosodic therapy, the prosodic abnormality score was improved, as were three of the four tests of recognition of the prosodic features of speech and facial expression, and two of the three tests of production (of angry and questioning forms). The apparent receptive disorder of speech in Parkinson's disease can thus respond to therapy. Possible mechanisms of improvement are briefly discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6707678      PMCID: PMC1027731          DOI: 10.1136/jnnp.47.3.302

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  4 in total

1.  The third element of speech: prosody in the neuro-psychiatric clinic.

Authors:  G H MONRAD-KROHN
Journal:  J Ment Sci       Date:  1957-04

2.  Speech therapy for patients with Parkinson's disease.

Authors:  S Scott; F I Caird
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-24

3.  Speech therapy for Parkinson's disease.

Authors:  S Scott; F I Caird
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

4.  A very short version of the Minnesota Aphasia Test.

Authors:  G E Powell; S Bailey; E Clark
Journal:  Br J Soc Clin Psychol       Date:  1980-06
  4 in total
  7 in total

1.  The interpretation of dysprosody in patients with Parkinson's disease.

Authors:  J F Caekebeke; A Jennekens-Schinkel; M E van der Linden; O J Buruma; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

2.  The response of the apparent receptive speech disorder of Parkinsonism to speech therapy.

Authors:  D E Hartman; J H Abbs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

Review 3.  Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson's disease.

Authors:  G Ransmayr
Journal:  J Neural Transm (Vienna)       Date:  2011-04-03       Impact factor: 3.575

4.  The Acoustic Voice Quality Index (AVQI) in People with Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.

Authors:  Gemma Moya-Galé; Jennifer Spielman; Lorraine A Ramig; Luca Campanelli; Youri Maryn
Journal:  J Voice       Date:  2022-04-18       Impact factor: 2.300

5.  Lithium-induced improvement of myotonia: relevance of prostaglandin E1 blockade by lithium.

Authors:  J Backon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

Review 6.  Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.

Authors:  Clare P Herd; Claire L Tomlinson; Katherine H O Deane; Marian C Brady; Christina H Smith; Catherine M Sackley; Carl E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

7.  A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.

Authors:  C M Sackley; C Rick; P Au; M C Brady; G Beaton; C Burton; M Caulfield; S Dickson; F Dowling; M Hughes; N Ives; S Jowett; P Masterson-Algar; A Nicoll; S Patel; C H Smith; R Woolley; C E Clarke
Journal:  Trials       Date:  2020-05-27       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.